29 results on '"Zygmunt MS"'
Search Results
2. The new strains Brucella inopinata BO1 and Brucella species 83-210 behave biologically like classic infectious Brucella species and cause death in murine models of infection.
- Author
-
Jiménez de Bagüés MP, Iturralde M, Arias MA, Pardo J, Cloeckaert A, and Zygmunt MS
- Subjects
- Animals, Cells, Cultured, Macrophages microbiology, Mice, Mice, Inbred Strains, Virulence, Brucella classification, Brucella pathogenicity, Brucellosis microbiology, Brucellosis mortality
- Abstract
Background: Recently, novel atypical Brucella strains isolated from humans and wild rodents have been reported. They are phenotypically close to Ochrobactrum species but belong to the genus Brucella, based on genetic relatedness, although genetic diversity is higher among the atypical Brucella strains than between the classic species. They were classified within or close to the novel species Brucella inopinata. However, with the exception of Brucella microti, the virulence of these novel strains has not been investigated in experimental models of infection., Methods: The type species B. inopinata strain BO1 (isolated from a human) and Brucella species strain 83-210 (isolated from a wild Australian rodent) were investigated. A classic infectious Brucella reference strain, B. suis 1330, was also used. BALB/c, C57BL/6, and CD1 mice models and C57BL/6 mouse bone-marrow-derived macrophages (BMDMs) were used as infection models., Results: Strains BO1 and 83-210 behaved similarly to reference strain 1330 in all mouse infection models: there were similar growth curves in spleens and livers of mice and similar intracellular replication rates in BMDMs. However, unlike strain 1330, strains BO1 and 83-210 showed lethality in the 3 mouse models., Conclusions: The novel atypical Brucella strains of this study behave like classic intracellular Brucella pathogens. In addition, they cause death in murine models of infection, as previously published for B. microti, another recently described environmental and wildlife species., (© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2014
- Full Text
- View/download PDF
3. Mutants in the lipopolysaccharide of Brucella ovis are attenuated and protect against B. ovis infection in mice.
- Author
-
Soler-Lloréns P, Gil-Ramírez Y, Zabalza-Baranguá A, Iriarte M, Conde-Álvarez R, Zúñiga-Ripa A, San Román B, Zygmunt MS, Vizcaíno N, Cloeckaert A, Grilló MJ, Moriyón I, and López-Goñi I
- Subjects
- Animals, Antibodies, Bacterial blood, Bacterial Proteins metabolism, Brucella Vaccine genetics, Brucellosis microbiology, Brucellosis veterinary, Female, Glycosyltransferases metabolism, Lipopolysaccharides metabolism, Mice, Mice, Inbred BALB C, Molecular Sequence Data, Oligosaccharides genetics, Oligosaccharides metabolism, Polymerase Chain Reaction veterinary, Sequence Analysis, DNA veterinary, Sheep, Sheep Diseases microbiology, Virulence, Bacterial Proteins genetics, Brucella Vaccine immunology, Brucella ovis immunology, Brucellosis immunology, Glycosyltransferases genetics, Lipopolysaccharides genetics, Sheep Diseases immunology
- Abstract
Brucella spp. are Gram-negative bacteria that behave as facultative intracellular parasites of a variety of mammals. This genus includes smooth (S) and rough (R) species that carry S and R lipopolysaccharides (LPS), respectively. S-LPS is a virulence factor, and mutants affected in the S-LPS O-polysaccharide (R mutants), core oligosaccharide or both show attenuation. However, B. ovis is naturally R and is virulent in sheep. We studied the role of B. ovis LPS in virulence by mutating the orthologues of wadA, wadB and wadC, three genes known to encode LPS core glycosyltransferases in S brucellae. When mapped with antibodies to outer membrane proteins (Omps) and R-LPS, wadB and wadC mutants displayed defects in LPS structure and outer membrane topology but inactivation of wadA had little or no effect. Consistent with these observations, the wadB and wadC but not the wadA mutants were attenuated in mice. When tested as vaccines, the wadB and wadC mutants protected mice against B. ovis challenge. The results demonstrate that the LPS core is a structure essential for survival in vivo not only of S brucellae but also of a naturally R Brucella pathogenic species, and they confirm our previous hypothesis that the Brucella LPS core is a target for vaccine development. Since vaccine B. melitensis Rev 1 is S and thus interferes in serological testing for S brucellae, wadB mutant represents a candidate vaccine to be evaluated against B. ovis infection of sheep suitable for areas free of B. melitensis.
- Published
- 2014
- Full Text
- View/download PDF
4. A potential novel Brucella species isolated from mandibular lymph nodes of red foxes in Austria.
- Author
-
Hofer E, Revilla-Fernández S, Al Dahouk S, Riehm JM, Nöckler K, Zygmunt MS, Cloeckaert A, Tomaso H, and Scholz HC
- Subjects
- Amino Acid Sequence, Animals, Austria, Base Sequence, Brucella isolation & purification, Brucellosis microbiology, Molecular Sequence Data, Phenotype, RNA, Ribosomal, 16S genetics, Sequence Alignment, Species Specificity, Brucella classification, Brucella genetics, Brucellosis veterinary, Foxes, Lymph Nodes microbiology
- Abstract
The wild red fox (Vulpes vulpes) is a known indicator species for natural foci of brucellosis. Here, we describe phenotypic and molecular characteristics of two atypical Brucella strains isolated from two foxes hunted 2008 in Eastern Austria. Both strains agglutinated with monospecific anti-Brucella A serum and were positive in ELISA with monoclonal antibodies directed against various Brucella lipopolysaccharide epitopes. However, negative nitrate reductase- and negative oxidase-reaction were atypical traits. Affiliation to the genus Brucella was confirmed by 16S rRNA gene sequencing and by detection of the Brucella specific insertion element IS711 and gene bcsp31 using real-time PCR. Both fox strains showed identical IS711 Southern blot profiles but were distinct from known brucellae. The number of IS711 copies detected was as high as found in B. ovis or marine mammal Brucella strains. Molecular analyses of the recA and omp2a/b genes suggest that both strains possibly represent a novel Brucella species., (Copyright © 2011 Elsevier B.V. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
5. Novel IS711 chromosomal location useful for identification of marine mammal Brucella genotype ST27, which is associated with zoonotic infection.
- Author
-
Cloeckaert A, Bernardet N, Koylass MS, Whatmore AM, and Zygmunt MS
- Subjects
- Animals, Brucella isolation & purification, Brucellosis microbiology, DNA, Bacterial chemistry, DNA, Bacterial genetics, Genotype, Molecular Sequence Data, New Zealand, Peru, Sequence Analysis, DNA, Brucella classification, Brucella genetics, Brucellosis veterinary, Chromosomes, Bacterial, DNA Transposable Elements, Mammals microbiology, Zoonoses microbiology
- Abstract
We report a novel IS711 chromosomal location that is specific for the Brucella genotype ST27 previously associated with Pacific marine mammals and human zoonotic infection in New Zealand and Peru. Our data support the previous observation that this peculiar genotype is distinct from those commonly isolated from the Atlantic and currently classified within the species B. ceti and B. pinnipedialis.
- Published
- 2011
- Full Text
- View/download PDF
6. Novel IS711-specific chromosomal locations useful for identification and classification of marine mammal Brucella strains.
- Author
-
Zygmunt MS, Maquart M, Bernardet N, Doublet B, and Cloeckaert A
- Subjects
- Animals, Bacterial Typing Techniques methods, Brucella isolation & purification, Brucellosis microbiology, DNA Fingerprinting methods, DNA, Bacterial chemistry, DNA, Bacterial genetics, Molecular Sequence Data, Sequence Analysis, DNA, Brucella classification, Brucella genetics, Brucellosis veterinary, DNA Transposable Elements, Mammals microbiology
- Abstract
We report five new IS711 chromosomal locations that are specific for marine mammal Brucella groups of strains and useful for their identification and classification. Our data support their current classification into two species, Brucella ceti and B. pinnipedialis, with subgroups in each, but also the possibility of additional species.
- Published
- 2010
- Full Text
- View/download PDF
7. Brucella inopinata sp. nov., isolated from a breast implant infection.
- Author
-
Scholz HC, Nöckler K, Göllner C, Bahn P, Vergnaud G, Tomaso H, Al Dahouk S, Kämpfer P, Cloeckaert A, Maquart M, Zygmunt MS, Whatmore AM, Pfeffer M, Huber B, Busse HJ, and De BK
- Subjects
- Aged, Bacterial Outer Membrane Proteins genetics, Bacterial Typing Techniques, Breast Implantation adverse effects, Brucella genetics, Brucella physiology, DNA, Ribosomal analysis, DNA, Ribosomal genetics, Fatty Acids analysis, Female, Genes, rRNA, Genotype, Humans, Minisatellite Repeats, Molecular Sequence Data, Nucleic Acid Hybridization, Phenotype, Phylogeny, RNA, Ribosomal, 16S genetics, Sequence Analysis, DNA, Species Specificity, Breast Implants microbiology, Brucella classification, Brucella isolation & purification, Brucellosis microbiology, Prosthesis-Related Infections microbiology
- Abstract
A Gram-negative, non-motile, non-spore-forming coccoid bacterium (strain BO1(T)) was isolated recently from a breast implant infection of a 71-year-old female patient with clinical signs of brucellosis. Affiliation of strain BO1(T) to the genus Brucella was confirmed by means of polyamine pattern, polar lipid profile, fatty acid profile, quinone system, DNA-DNA hybridization studies and by insertion sequence 711 (IS711)-specific PCR. Strain BO1(T) harboured four to five copies of the Brucella-specific insertion element IS 711, displaying a unique banding pattern, and exhibited a unique 16S rRNA gene sequence and also grouped separately in multilocus sequence typing analysis. Strain BO1(T) reacted with Brucella M-monospecific antiserum. Incomplete lysis was detected with bacteriophages Tb (Tbilisi), F1 and F25. Biochemical profiling revealed a high degree of enzymic activity and metabolic capabilities. In multilocus VNTR (variable-number tandem-repeat) analysis, strain BO1(T) showed a very distinctive profile and clustered with the other 'exotic' Brucella strains, including strains isolated from marine mammals, and Brucella microti, Brucella suis biovar 5 and Brucella neotomae. Comparative omp2a and omp2b gene sequence analysis revealed the most divergent omp2 sequences identified to date for a Brucella strain. The recA gene sequence of strain BO1(T) differed in seven nucleotides from the Brucella recA consensus sequence. Using the Brucella species-specific multiplex PCR assay, strain BO1(T) displayed a unique banding pattern not observed in other Brucella species. From the phenotypic and molecular analysis it became evident that strain BO1( T) was clearly different from all other Brucella species, and therefore represents a novel species within the genus Brucella. Because of its unexpected isolation, the name Brucella inopinata with the type strain BO1(T) (=BCCN 09-01(T)=CPAM 6436(T)) is proposed.
- Published
- 2010
- Full Text
- View/download PDF
8. Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep.
- Author
-
Barrio MB, Grilló MJ, Muñoz PM, Jacques I, González D, de Miguel MJ, Marín CM, Barberán M, Letesson JJ, Gorvel JP, Moriyón I, Blasco JM, and Zygmunt MS
- Subjects
- Animals, Enzyme-Linked Immunosorbent Assay, Female, Freeze Drying, Macrophages microbiology, Male, Mice, Mutation immunology, Pregnancy, Sheep, Vaccination, Antibodies, Bacterial biosynthesis, Bacterial Vaccines immunology, Brucella melitensis immunology, Brucellosis immunology, Brucellosis veterinary, Lipopolysaccharides biosynthesis, Lipopolysaccharides genetics, Sheep Diseases immunology
- Abstract
Classical brucellosis vaccines induce antibodies to the O-polysaccharide section of the lipopolysaccharide that interfere in serodiagnosis. Brucella rough (R) mutants lack the O-polysaccharide but their usefulness as vaccines is controversial. Here, Brucella melitensis R mutants in all main lipopolysaccharide biosynthetic pathways were evaluated in sheep in comparison with the reference B. melitensis Rev 1 vaccine. In a first experiment, these mutants were tested for ability to induce anti-O-polysaccharide antibodies, persistence and spread through target organs, and innocuousness. Using the data obtained and those of genetic studies, three candidates were selected and tested for efficacy as vaccines against a challenge infecting 100% of unvaccinated ewes. Protection by R vaccines was 54% or less whereas Rev 1 afforded 100% protection. One-third of R mutant vaccinated ewes became positive in an enzyme-linked immunosorbent assay with smooth lipopolysaccharide due to the core epitopes remaining in the mutated lipopolysaccharide. We conclude that R vaccines interfere in lipopolysaccharide immunosorbent assays and are less effective than Rev 1 against B. melitensis infection of sheep.
- Published
- 2009
- Full Text
- View/download PDF
9. Marine mammal Brucella isolates with different genomic characteristics display a differential response when infecting human macrophages in culture.
- Author
-
Maquart M, Zygmunt MS, and Cloeckaert A
- Subjects
- Animals, Brucella isolation & purification, Brucellosis microbiology, Cell Line, Humans, Virulence, Brucella immunology, Brucella pathogenicity, Brucellosis veterinary, Macrophages immunology, Macrophages microbiology, Mammals microbiology
- Abstract
Marine mammal Brucella strains with different genomic characteristics according to distribution of IS711 elements in their genomes were analysed for their intracellular behaviour in human THP-1 macrophage-like cells. Seven different groups of marine mammal strains were identified including a human isolate from New Zealand presumably from marine origin. Entry and intracellular survival of strains representative of these groups in THP-1 human macrophage-like cells were analysed at several times of infection. Three patterns of infection were identified. The Brucella strain isolated from the human case from New Zealand, and two other groups of strains belonging to B. ceti or B. pinnipedialis were able to infect THP-1 macrophage cells to the same extent as the virulent strains B. suis 1330 or B. melitensis 16M. Three other groups of strains belonging to B. ceti or B. pinnipedialis were able to enter the cells as classical virulent strains but were eliminated after 48h. The last group was composed only of strains isolated from hooded seals (Cystophora cristata) and was even unable to enter and infect THP-1 macrophage cells. Thus, several groups of marine mammal Brucella strains appear to be non-infectious for human macrophages.
- Published
- 2009
- Full Text
- View/download PDF
10. Brucella microti sp. nov., isolated from the common vole Microtus arvalis.
- Author
-
Scholz HC, Hubalek Z, Sedlácek I, Vergnaud G, Tomaso H, Al Dahouk S, Melzer F, Kämpfer P, Neubauer H, Cloeckaert A, Maquart M, Zygmunt MS, Whatmore AM, Falsen E, Bahn P, Göllner C, Pfeffer M, Huber B, Busse HJ, and Nöckler K
- Subjects
- Animals, Bacterial Outer Membrane Proteins genetics, Bacterial Typing Techniques, Brucella genetics, Brucella physiology, Brucellosis microbiology, DNA, Bacterial analysis, Genes, rRNA, Genotype, Minisatellite Repeats genetics, Molecular Sequence Data, Nucleic Acid Hybridization, Phenotype, Phylogeny, RNA, Ribosomal, 16S genetics, Rec A Recombinases genetics, Sequence Analysis, DNA, Species Specificity, Arvicolinae microbiology, Brucella classification, Brucella isolation & purification, Brucellosis veterinary, Rodent Diseases microbiology
- Abstract
Two Gram-negative, non-motile, non-spore-forming, coccoid bacteria (strains CCM 4915(T) and CCM 4916), isolated from clinical specimens of the common vole Microtus arvalis during an epizootic in the Czech Republic in 2001, were subjected to a polyphasic taxonomic study. On the basis of 16S rRNA (rrs) and recA gene sequence similarities, both isolates were allocated to the genus Brucella. Affiliation to Brucella was confirmed by DNA-DNA hybridization studies. Both strains reacted equally with Brucella M-monospecific antiserum and were lysed by the bacteriophages Tb, Wb, F1 and F25. Biochemical profiling revealed a high degree of enzyme activity and metabolic capabilities not observed in other Brucella species. The omp2a and omp2b genes of isolates CCM 4915(T) and CCM 4916 were indistinguishable. Whereas omp2a was identical to omp2a of brucellae from certain pinniped marine mammals, omp2b clustered with omp2b of terrestrial brucellae. Analysis of the bp26 gene downstream region identified strains CCM 4915(T) and CCM 4916 as Brucella of terrestrial origin. Both strains harboured five to six copies of the insertion element IS711, displaying a unique banding pattern as determined by Southern blotting. In comparative multilocus VNTR (variable-number tandem-repeat) analysis (MLVA) with 296 different genotypes, the two isolates grouped together, but formed a separate cluster within the genus Brucella. Multilocus sequence typing (MLST) analysis using nine different loci also placed the two isolates separately from other brucellae. In the IS711-based AMOS PCR, a 1900 bp fragment was generated with the Brucella ovis-specific primers, revealing that the insertion element had integrated between a putative membrane protein and cboL, encoding a methyltransferase, an integration site not observed in other brucellae. Isolates CCM 4915(T) and CCM 4916 could be clearly distinguished from all known Brucella species and their biovars by means of both their phenotypic and molecular properties, and therefore represent a novel species within the genus Brucella, for which the name Brucella microti sp. nov. with the type strain CCM 4915(T) (=BCCN 07-01(T)=CAPM 6434(T)) is proposed.
- Published
- 2008
- Full Text
- View/download PDF
11. Identification of Brucella melitensis 16M genes required for bacterial survival in the caprine host.
- Author
-
Zygmunt MS, Hagius SD, Walker JV, and Elzer PH
- Subjects
- Animals, Bacterial Proteins genetics, Brucella melitensis growth & development, Brucella melitensis pathogenicity, DNA Helicases genetics, Goats, Liver microbiology, Lymph Nodes microbiology, Mutagenesis, Phosphotransferases (Alcohol Group Acceptor) genetics, Spleen microbiology, Virulence, Brucella melitensis genetics, Brucellosis microbiology, Genes, Bacterial, Goat Diseases microbiology
- Abstract
Brucella species are gram-negative bacteria which belong to alpha-Proteobacteria family. These organisms are zoonotic pathogens that induce abortion and sterility in domestic mammals and chronic infections in humans known as Malta fever. The virulence of Brucella is dependent upon its ability to enter and colonize the cells in which it multiplies. The genetic basis of this aspect is poorly understood. Signature-tagged mutagenesis (STM) was used to identify potential Brucella virulence factors. PCR amplification has been used in place of DNA hybridization to identify the STM-generated attenuated mutants. A library of 288 Brucella melitensis 16M tagged mini-Tn5 Km2 mutants, in 24 pools, was screened for its ability to colonize spleen, lymph nodes and liver of goats at three weeks post-i.v. infection. This comparative screening identified 7 mutants (approximately 5%) which were not recovered from the output pool in goats. Some genes were known virulence genes involved in biosynthesis of LPS (lpsA gene) or in intracellular survival (the virB operon). Other mutants included ones which had a disrupted gene homologous to flgF, a gene coding for the basal-body rod of the flagellar apparatus, and another with a disruption in a gene homologous to ppk which is involved in the biosynthesis of inorganic polyphosphate (PolyP) from ATP. Other genes identified encoded factors involved in DNA metabolism and oxidoreduction metabolism. Using STM and the caprine host for screening, potential virulence determinants in B. melitensis have been identified.
- Published
- 2006
- Full Text
- View/download PDF
12. Development of a multiplex PCR assay for polymorphism analysis of Brucella suis biovars causing brucellosis in swine.
- Author
-
Ferrão-Beck L, Cardoso R, Muñoz PM, de Miguel MJ, Albert D, Ferreira AC, Marín CM, Thiébaud M, Jacques I, Grayon M, Zygmunt MS, Garin-Bastuji B, Blasco JM, and Sá MI
- Subjects
- Amino Acid Sequence, Animals, Bacterial Proteins chemistry, Base Sequence, Brucella suis classification, Brucella suis isolation & purification, Brucellosis diagnosis, Brucellosis microbiology, DNA, Bacterial chemistry, Gene Amplification, Molecular Sequence Data, Phylogeny, Polymerase Chain Reaction methods, Polymorphism, Single Nucleotide, Porins chemistry, Swine, Swine Diseases diagnosis, Bacterial Proteins genetics, Brucella suis genetics, Brucellosis veterinary, Polymerase Chain Reaction veterinary, Polymorphism, Genetic, Porins genetics, Swine Diseases microbiology
- Abstract
Swine brucellosis is caused by the biovars 1, 2 and 3 of Brucella suis the identification of which up to now relies on microbiological tests lacking adequate specificity together with time consuming and expensive molecular procedures. Based on sequence variation of the omp2b gene, we have developed a four primer set multiplex PCR assay that was tested for polymorphism analysis of B. suis biovars causing brucellosis in swine. The assay exploits the single nucleotide polymorphisms found in omp2b gene of B. suis reference biovars which are conserved in 43 B. suis field isolates from different geographic origins and hosts. Three specific amplification patterns (S1, S2 and S3) were obtained for reference strains of B. suis biovars 1, 2 and 3, respectively. However, some B. suis field isolates identified as biovars 2 or 3 according AMOS-PCR, PCR-RFLP of omp31 and omp2 genes and classical bacteriological methods, resulted also in S1 patterns, limiting the typing usefulness of the method.
- Published
- 2006
- Full Text
- View/download PDF
13. Epitope mapping of the Brucella melitensis BP26 immunogenic protein: usefulness for diagnosis of sheep brucellosis.
- Author
-
Seco-Mediavilla P, Verger JM, Grayon M, Cloeckaert A, Marín CM, Zygmunt MS, Fernández-Lago L, and Vizcaíno N
- Subjects
- Amino Acid Sequence, Animals, Antigens, Bacterial genetics, Bacterial Proteins genetics, Brucella melitensis genetics, Brucella ovis immunology, Brucella suis immunology, Brucellosis diagnosis, Brucellosis microbiology, Genes, Bacterial, Immunodominant Epitopes genetics, Membrane Proteins genetics, Molecular Sequence Data, Recombinant Fusion Proteins immunology, Sequence Alignment, Sequence Homology, Amino Acid, Sheep, Sheep Diseases microbiology, Species Specificity, Antigens, Bacterial immunology, Bacterial Proteins immunology, Brucella melitensis immunology, Brucellosis veterinary, Epitope Mapping, Immunodominant Epitopes immunology, Membrane Proteins immunology, Sheep Diseases diagnosis
- Abstract
Sequencing of bp26, the gene encoding the Brucella sp. immunogenic BP26 periplasmic protein, was performed in the reference strains of Brucella abortus, B. suis, and B. ovis. The three bp26 sequences were almost identical to that published for B. melitensis 16M bp26, and only minor nucleotide substitutions, without modifying the amino acid sequence, were observed between species. The bp26 genes of the seven B. abortus biovar reference strains and B. abortus S19 and RB51 vaccine strains were also sequenced. Again, only minor differences were found. Surprisingly, the bp26 nucleotide sequence for B. abortus S19 was almost identical to that found for B. melitensis 16M and differed from the sequence described previously by others (O. L. Rossetti, A. I. Arese, M. L. Boschiroli, and S. L. Cravero, J. Clin. Microbiol. 34:165-169, 1996) for the same B. abortus strain. The epitope mapping of BP26, performed by using a panel of monoclonal antibodies and recombinant DNA techniques, allowed the identification of an immunodominant region of the protein interesting for the diagnosis of B. melitensis and B. ovis infection in sheep. A recombinant fusion protein containing this region of BP26 reacted indeed, in Western blotting, as the entire recombinant BP26 against sera from B. melitensis- or B. ovis-infected sheep while it avoided false-positive reactions observed with sera from Brucella-free sheep when using the entire recombinant BP26. Thus, use of this recombinant fusion protein instead the entire recombinant BP26 could improve the specific serological diagnosis of B. melitensis or B. ovis infection in sheep.
- Published
- 2003
- Full Text
- View/download PDF
14. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.
- Author
-
Estein SM, Cassataro J, Vizcaíno N, Zygmunt MS, Cloeckaert A, and Bowden RA
- Subjects
- Animals, Antibodies, Bacterial blood, Bacterial Outer Membrane Proteins genetics, Bacterial Vaccines administration & dosage, Brucella metabolism, Brucella pathogenicity, Brucella melitensis genetics, Brucella melitensis metabolism, Female, Immunization, Mice, Mice, Inbred BALB C, Recombinant Proteins genetics, Recombinant Proteins immunology, Sheep, Spleen microbiology, Bacterial Outer Membrane Proteins immunology, Bacterial Vaccines immunology, Brucella immunology, Brucella melitensis immunology, Brucellosis prevention & control, Lipopolysaccharides immunology
- Abstract
Immunogenicity and protective activity against Brucella ovis of detergent-extracted recombinant Omp31 (rOmp31 extract) from Brucella melitensis produced in Escherichia coli, purified rough lipopolysaccharide from B. ovis (R-LPS) and a mixture of rOmp31 extract and R-LPS (rOmp31 extract + R-LPS) were assessed in BALB/c mice. The experimental vaccines were compared with a hot saline extract (HS extract) from B. ovis mainly composed of outer membrane proteins (OMPs) and R-LPS, and known to be protective in mice against a B. ovis infection. Serum antibodies to Omp31 and R-LPS were detected in the corresponding mice using Western blotting with B. ovis whole-cell lysates and ELISA with purified antigens. Protection was evaluated by comparing the levels of infection in the spleens of vaccinated mice challenged with B. ovis. A significantly lower number of B. ovis colony-forming units in spleens relative to unimmunized (saline injected) controls were considered as protection. Mice immunized with rOmp31 extract or rOmp31 extract mixed with R-LPS developed antibodies that bound to the B. ovis surface with similar titers. Vaccination with rOmp31 extract plus R-LPS provided the best protection level, which was comparable with that given by HS extract. Similar protection was also obtained with rOmp31 extract alone and, to a lesser degree, with R-LPS. Comparisons between groups showed that an extract from E. coli-pUC19 (devoid of Omp31) provided no protection relative to either HS extract, rOmp31 extract or rOmp31 extract mixed with R-LPS. In conclusion, the recombinant Omp31 associated or not with B. ovis R-LPS, could be an interesting candidate for a subcellular vaccine against B. ovis infection.
- Published
- 2003
- Full Text
- View/download PDF
15. Single-step purification and evaluation of recombinant BP26 protein for serological diagnosis of Brucella ovis infection in rams.
- Author
-
Zygmunt MS, Baucheron S, Vizcaino N, Bowden RA, and Cloeckaert A
- Subjects
- Animals, Antibodies, Bacterial blood, Blotting, Western veterinary, Brucellosis diagnosis, Brucellosis microbiology, Chromatography, Ion Exchange veterinary, Electrophoresis, Polyacrylamide Gel veterinary, Enzyme-Linked Immunosorbent Assay methods, Escherichia coli chemistry, Escherichia coli genetics, Escherichia coli metabolism, Male, Recombinant Proteins isolation & purification, Sheep, Sheep Diseases diagnosis, Brucella isolation & purification, Brucellosis veterinary, Enzyme-Linked Immunosorbent Assay veterinary, Membrane Proteins isolation & purification, Sheep Diseases microbiology
- Abstract
To investigate the value of the BP26 protein in the serological diagnosis of ovine brucellosis caused by Brucella ovis, recombinant BP26 protein was produced in Echerichia coli and purified for use in an indirect enzyme-linked immunosorbent assay (I-ELISA). The majority of the recombinant protein was recovered from the supernatant of sonicated recombinant E. coli cells in a soluble form. This facilitated the purification of the recombinant BP26 protein which was achieved by using ion-exchange chromatography. After one step of purification, the purity of the recombinant BP26 protein was analyzed by using SDS-PAGE, Coomassie blue staining, and Western blot with a monoclonal antibody (MAb) directed against the BP26 protein. The degree of purity appeared satisfactory so that it could be directly used in I-ELISA. Although the recombinant BP26-ELISA appeared less useful than I-ELISA using the B. ovis hot saline (HS) extract as antigen, the high number of sera from B. ovis infected rams found positive (90%) in the recombinant BP26-I-ELISA indicated that the BP26 protein may be an additional suitable antigen for serological diagnosis of B. ovis infection in rams.
- Published
- 2002
- Full Text
- View/download PDF
16. Cloning, nucleotide sequence, and expression of the Brucella melitensis sucB gene coding for an immunogenic dihydrolipoamide succinyltransferase homologous protein.
- Author
-
Zygmunt MS, Díaz MA, Teixeira-Gomes AP, and Cloeckaert A
- Subjects
- Acyltransferases immunology, Animals, Antibodies, Bacterial immunology, Antibodies, Monoclonal immunology, Antibody Specificity, Base Sequence, Brucella melitensis genetics, Brucellosis blood, Brucellosis immunology, Cloning, Molecular, DNA, Bacterial, Escherichia coli, Gene Expression, Genes, Bacterial, Molecular Sequence Data, Sequence Analysis, DNA, Sheep, Sheep Diseases blood, Acyltransferases genetics, Brucella melitensis enzymology, Brucellosis veterinary, Sheep Diseases immunology
- Abstract
The Brucella melitensis sucB gene encoding the dihydrolipoamide succinyltransferase (E2o) enzyme (previously identified as an immunogenic protein in infected sheep) was cloned and sequenced. The amino acid sequence predicted from the cloned gene revealed 88.8 and 51.2% identity to the dihydrolipoamide succinyltransferase SucB protein from Brucella abortus and Escherichia coli, respectively. Sera from naturally infected sheep showed antibody reactivity against the recombinant SucB protein.
- Published
- 2001
- Full Text
- View/download PDF
17. Use of recombinant BP26 protein in serological diagnosis of Brucella melitensis infection in sheep.
- Author
-
Cloeckaert A, Baucheron S, Vizcaino N, and Zygmunt MS
- Subjects
- Animals, Antigens, Bacterial genetics, Bacterial Proteins genetics, Brucellosis blood, Brucellosis diagnosis, Brucellosis immunology, Enzyme-Linked Immunosorbent Assay methods, Membrane Proteins genetics, Recombinant Fusion Proteins genetics, Recombinant Fusion Proteins immunology, Sensitivity and Specificity, Sheep, Sheep Diseases blood, Sheep Diseases immunology, Antigens, Bacterial immunology, Bacterial Proteins immunology, Brucella melitensis immunology, Brucellosis veterinary, Membrane Proteins immunology, Sheep Diseases diagnosis
- Abstract
Previously a Brucella protein named CP28, BP26, or Omp28 has been identified as an immunodominant antigen in infected cattle, sheep, goats, and humans. In the present study we evaluated antibody responses of infected and B. melitensis Rev.1-vaccinated sheep to the BP26 protein using purified recombinant BP26 protein produced in Escherichia coli in an indirect enzyme-linked immunosorbent assay (I-ELISA). The specificity of the I-ELISA determined with sera from healthy sheep (n = 106) was 93%. The sensitivity of the I-ELISA assessed with sera from naturally infected and suspected sheep found positive in the current conventional diagnostic tests was as follows: 100% for bacteriologically and serologically positive sheep (n = 50), 88% for bacteriologically negative but serologically and delayed-type hypersensitivity-positive sheep (n = 50), and 84% for bacteriologically and serologically negative but delayed-type hypersensitivity-positive sheep (n = 19). However, the absorbance values observed did not reach those observed in an I-ELISA using purified O-polysaccharide (O-PS) as an antigen. In sheep experimentally infected with B. melitensis H38 the antibody response to BP26 was delayed and much weaker than that to O-PS. Nevertheless, the BP26 protein appears to be a good diagnostic antigen to be used in confirmatory tests and for serological differentiation between infected and B. melitensis Rev.1-vaccinated sheep. Weak antibody responses to BP26 in some of the latter sheep suggest that a B. melitensis Rev.1 bp26 gene deletion mutant should be constructed to ensure this differentiation.
- Published
- 2001
- Full Text
- View/download PDF
18. Identification of protective outer membrane antigens of Brucella ovis by passive immunization of mice with monoclonal antibodies.
- Author
-
Bowden RA, Estein SM, Zygmunt MS, Dubray G, and Cloeckaert A
- Subjects
- Animals, Antigens, Bacterial analysis, Antigens, Bacterial immunology, Blotting, Western, Brucellosis microbiology, Drug Therapy, Combination, Immunization, Passive, Lipopolysaccharides immunology, Mice, Antibodies, Bacterial therapeutic use, Antibodies, Monoclonal therapeutic use, Bacterial Outer Membrane Proteins immunology, Brucella, Brucellosis therapy
- Abstract
Outer membrane proteins (OMPs) and rough lipopolysaccharide (R-LPS), the main surface antigens of Brucella ovis, display surface-exposed epitopes. Mixtures of monoclonal antibodies (mAbs) to both antigens were previously shown to protect mice against a B. ovis challenge. To further identify the antigens involved, seven mAbs against Brucella OMPs (Omp10, Omp16, Omp19, Omp25, Omp31, Omp2b and Omp1) and three to R-LPS were tested for protection either individually or in combinations. Significant reduction in spleen infection in challenged mice, relative to controls, was used as the protection criteri. Controls included nonimmunized mice and mice given an irrelevant, anti-O-polysaccharide (OPS), mAb. For comparison, a group received a mouse serum containing antibodies to both OMPs and R-LPS; this serum was prepared by immunization with a B. ovis hot-saline extract which, as described previously, induces protective immunity in mice and rams. Significant protection was observed with both mAbs to OMPs and R-LPS. mAbs to Omp16, Omp19 and Omp31 afforded the highest protection and prevented the development of splenomegaly. The protective effect of mAb to Omp31 was not interfered with by nonprotective mAbs in different mixtures. The data presented confirm the protective role of antibodies to OMPs and R-LPS against B. ovis, and identify several OMPs, especially Omp31, which are promising candidates for a subunit vaccine against ram epididymitis.
- Published
- 2000
- Full Text
- View/download PDF
19. O-Polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometry.
- Author
-
Cloeckaert A, Weynants V, Godfroid J, Verger JM, Grayon M, and Zygmunt MS
- Subjects
- Animals, Antibodies, Monoclonal, Epitopes, Humans, Mice, Serotyping, Brucella classification, Brucella immunology, Brucellosis microbiology, Enzyme-Linked Immunosorbent Assay methods, Flow Cytometry methods, Lipopolysaccharides immunology
- Abstract
Smooth Brucella strains are classified into three serotypes, i.e., A+M-, A-M+, and A+M+, according to slide agglutination with A and M monospecific polyclonal sera. The epitopes involved have been located on the O-polysaccharide (O-PS) moiety of the smooth lipopolysaccharide (S-LPS), which represents the most exposed antigenic structure on the surface of Brucella spp. By use of monoclonal antibodies (MAbs) a number of epitope specificities on the O-PS have been reported: A, M, and epitopes shared by both A and M dominant strains, which have been named common (C) epitopes. The latter have been further subdivided, according to relative MAb binding in enzyme-linked immunosorbent assays (ELISA) to A- and M-dominant Brucella strains and to cross-reacting Yersinia enterocolitica O:9, into five epitopic specificities: C (M>A), C (M=A), C/Y (M>A), C/Y (M=A), and C/Y (A>M). In the present study, we studied the occurrence of these epitopes at the surface of representatives of all Brucella species and biovars including the live vaccine strains by analyzing the levels of MAb binding to whole Brucella cells in ELISA and flow cytometry assays. In ELISA, the level of MAb binding correlated well with the previously defined epitope specificity and the serotype defined by polyclonal sera for each Brucella species, biovar, or strain. However, MAbs to the C (M=A) and C (M>A) epitopes showed insignificant binding to B. suis biovar 2 strains and bound at lower titers to B. suis biovar 3 and B. neotomae than to the other Brucella strains. Some of the flow cytometry results were contradictory to those obtained by ELISA. In fact, it appeared by flow cytometry that all O-PS epitopes, including the A and M epitopes, are shared to different degrees by Brucella spp. which nevertheless show a high degree of O-PS heterogeneity according to MAb binding intensities. The subdivision of MAb specificities and Brucella serotypes was therefore less evident by flow cytometry than by ELISA. Whereas in ELISA the MAb specific for the A epitope showed insignificant binding to Y. enterocolitica O:9, this MAb bound strongly to Y. enterocolitica O:9 in flow cytometry. One of the two MAbs specific to the C (M=A) epitope also bound at a low but significant level to B. suis biovar 2 strains. However, as in ELISA the MAb specific for the C (M>A) epitope did not bind at all to B. suis biovar 2 strains in flow cytometry. Flow cytometry provided new information regarding specificity of the MAbs and may further explain some aspects of the capacity of passive protection of some MAbs against smooth Brucella infection in mice. As shown in the present study the occurrence of Brucella strains apparently completely devoid of one specific C O-PS epitope (e.g., B. suis biovar 2 devoid of the C [M>A] epitope) offers the possibility of obtaining vaccine strains devoid of a diagnostic O-PS epitope, which could further help to resolve the problem of discriminating infected from vaccinated animals that remains a major goal in brucellosis research.
- Published
- 1998
- Full Text
- View/download PDF
20. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli.
- Author
-
Bowden RA, Cloeckaert A, Zygmunt MS, and Dubray G
- Subjects
- Animals, Antibodies, Monoclonal immunology, Antibody Specificity, Bacterial Outer Membrane Proteins biosynthesis, Bacterial Outer Membrane Proteins genetics, Brucella melitensis genetics, Brucellosis immunology, Cells, Cultured, Electrophoresis, Polyacrylamide Gel, Enzyme-Linked Immunosorbent Assay, Escherichia coli genetics, Female, Flow Cytometry, Gene Expression Regulation, Bacterial, Immune Sera immunology, Immunization, Immunization, Secondary, Immunoblotting, Immunoglobulin G biosynthesis, Interferon-gamma biosynthesis, Mice, Mice, Inbred BALB C, Random Allocation, Spleen cytology, Spleen immunology, Spleen microbiology, Antibodies, Bacterial biosynthesis, Bacterial Outer Membrane Proteins immunology, Brucella melitensis immunology, Brucellosis prevention & control
- Abstract
The antibody response specific to the 25-kDa major outer-membrane protein (Omp25) of Brucella melitensis expressed in Escherichia coli was assessed in BALB/c mice. Groups of mice were immunised and boosted either with sonicated E. coli carrying plasmid pAC2533-E. coli (pAC2533)-expressing the gene coding for Omp25 (omp25 gene) of B. melitensis, or with E. coli carrying plasmid pUC19-E. coli (pUC19). One control group received saline. The evolution of antibody responses was investigated by indirect ELISA with whole rough (R) B. melitensis H38 cells as antigen. Serum antibody titres of mice immunised with E. coli (pAC2533) were appreciably higher than those of mice immunised with E. coli (pUC19). The specificity to Omp25 of murine antibodies induced by E. coli (pAC2533) was demonstrated by SDS-PAGE and immunoblotting of five B. melitensis strains. Binding of antibody in E. coli (pAC2533) immune sera to the surface of B. melitensis strains differing in their smooth lipopolysaccharide (S-LPS) expression was also studied by whole-cell ELISA and by flow cytometry. Antibody reactivity to R and smooth-rough (S-R) was much stronger than that to smooth (S) B. melitensis strains, indicating a much better accessibility of Omp25 to antibody on strains lacking or expressing less O-polysaccharide on their surface. The antibodies to Omp25 were predominantly of IgG2a isotype. The capacity of E. coli (pAC2533) to induce protective immune responses against four challenge strains of B. melitensis was further evaluated in mice. Significant reductions in splenic infections, in comparison with mice immunised with E. coli (pUC19) and unimmunised (saline injection) mice, were observed in R B. melitensis B115, S-R B. melitensis EP and S B. melitensis H38 infected mice. Protection against S B. melitensis 16M was not significant. The data from the present study, together with previous results, suggest that humoral immunity against probably conformational, well-exposed epitopes of the Omp25 could contribute to protective mechanisms against B. melitensis infection in mice.
- Published
- 1998
- Full Text
- View/download PDF
21. Identification of the major T-cell antigens present in the Brucella melitensis B115 protein preparation, Brucellergene OCB.
- Author
-
Denoel PA, Vo TK, Weynants VE, Tibor A, Gilson D, Zygmunt MS, Limet JN, and Letesson JJ
- Subjects
- Animals, Blotting, Western, Brucellosis, Bovine immunology, Cattle, Guinea Pigs, Hypersensitivity, Delayed, Interferon-gamma biosynthesis, Lymphocyte Activation, Allergens immunology, Antigens, Bacterial immunology, Bacterial Proteins, Brucella melitensis immunology, Brucellosis immunology, Cytochrome b Group immunology, Ferritins immunology, T-Lymphocytes immunology
- Abstract
Brucellergene is a commercial allergen prepared from Brucella melitensis strain B115 and containing at least 20 cytoplasmic proteins. These proteins were separated by SDS-PAGE. The unstained gel was divided into 18 fractions and proteins were eluted from the gel fractions. The capacity of the separated proteins to elicit delayed-type hypersensitivity (DTH) in infected guinea-pigs or to induce the production of interferon-gamma (IFN-gamma) by blood cells from infected cattle was evaluated. The biological activity of the corresponding protein fractions blotted on to nitrocellulose was measured in a lymphocyte blastogenesis assay. Among the 18 fractions tested, two-spanning the mol. wt ranges 17-22 (fraction 8) and 35-42-kDa (fraction 17)-showed the maximum biological activity in the three tests. These fractions contain two antigens, the Brucella bacterioferritin (BFR) and P39 proteins. Both proteins are good candidates for the detection of cellular immunity to Brucella.
- Published
- 1997
- Full Text
- View/download PDF
22. Competitive enzyme-linked immunosorbent assay using monoclonal antibodies to the Brucella melitensis BP26 protein to evaluate antibody responses in infected and B. melitensis Rev.1 vaccinated sheep.
- Author
-
Debbarh HS, Zygmunt MS, Dubray G, and Cloeckaert A
- Subjects
- Animals, Antibodies, Monoclonal, Antibody Formation, Antibody Specificity, Bacterial Proteins immunology, Brucellosis immunology, Brucellosis prevention & control, Enzyme-Linked Immunosorbent Assay, Sheep, Antibodies, Bacterial blood, Bacterial Vaccines, Brucella melitensis immunology, Brucellosis veterinary, Membrane Proteins immunology, Sheep Diseases
- Abstract
Competitive enzyme-linked immunosorbent assay (C-ELISA) was performed using 15 monoclonal antibodies (MAbs), specific for Brucella BP26 (previously also called CP28), a periplasmic protein antigen, to investigate antibody responses in naturally and B. melitensis H38 experimentally infected and B. melitensis Rev.1 vaccinated sheep. The antigen preparation consisted of cytosoluble protein extract (CPE) of B. melitensis B115. By combining the C-ELISA results of several MAbs, a high percentage of naturally infected animals were detected which showed different status in the current conventional diagnostic tests. Indeed, 90% of sheep which were positive in the conventional bacteriological and serological tests were positive in C-ELISA. 72% of the bacteriologically negative but serologically and delayed type hypersensitivity positive sheep were also positive in the C-ELISA. Moreover, 79% of the bacteriologically and serologically negative sheep but delayed type hypersensitivity positive were also detected by C-ELISA. Thus, these results confirmed the importance of BP26 as a frequently recognized target of the humoral immune response of infected sheep. The 8 B. melitensis H38 experimentally infected sheep showed various degrees of antibody responses at the 90th day after infection, which was delayed in comparison to that against O-polysaccharide (O-PS). Of the 15 MAbs tested, only one MAb was weakly inhibited (20 to 35% inhibition) by 56% of negative control sera. Furthermore, no antibody response against BP26 was detected in B. melitensis Rev.1 vaccinated sheep. Results of the C-ELISA with the 15 MAbs showed individual variability of the antibody responses against BP26. Thus, it is suggested that several epitopes of BP26 are of interest for diagnosis of B. melitensis infection in sheep.
- Published
- 1996
- Full Text
- View/download PDF
23. Production and characterisation of monoclonal antibodies to Brucella melitensis cytosoluble proteins that are able to differentiate antibody responses of infected sheep from Rev. 1 vaccinated sheep.
- Author
-
Cloeckaert A, Debbarh HS, Zygmunt MS, and Dubray G
- Subjects
- Animals, Brucella Vaccine immunology, Cell Wall immunology, Cytosol immunology, Female, Immunoblotting, Mice, Mice, Inbred BALB C, Microscopy, Immunoelectron, Sheep, Antibodies, Monoclonal biosynthesis, Antibodies, Monoclonal immunology, Bacterial Proteins immunology, Brucella melitensis immunology, Brucellosis immunology, Brucellosis veterinary, Sheep Diseases immunology
- Abstract
Monoclonal antibodies (MAbs) were produced to Brucella melitensis cytosoluble proteins (CP) with apparent molecular masses of 12, 24 and 28 kDa (CP12, CP24 and CP28) which were previously shown by immunoblotting to differentiate antibody responses of infected sheep from those of B. melitensis strain Rev. 1 vaccinated sheep. These MAbs were derived from mice infected with virulent smooth (S) B. melitensis strain H38. Most MAbs obtained were directed to CP28, which indicated (as was shown in infected sheep) that this protein was also highly immunogenic in mice. A large number of MAbs that showed reactivity to CP in ELISA but did not show reactivity in immunoblotting of CP were also obtained and might recognise conformational epitopes of these proteins. MAbs were used to localise CP12, CP24 and CP28. None of the MAbs reacted with whole B. melitensis cells in ELISA but showed reactivity with sonicated bacteria in ELISA, which indicated an internal localisation of these proteins. Among several B. melitensis B115 subcellular fractions tested, the anti-CP12 and anti-CP28 MAbs reacted essentially with the CP extract (CPE) in both ELISA and immunoblotting, whereas the anti-CP24 MAbs reacted with both CPE and cell envelope fraction (CEF)-although with lower intensity to the latter fraction. The internal localisation of these proteins was confirmed by immuno-electron microscopy of thin-sectioned B. melitensis B115 or B. melitensis 16M cells. Immunogold labelling was mainly observed in the cytoplasm and, consequently, CP12, CP24 and CP28 are probably cytoplasmic proteins. Immunoblotting of whole cell lysates with the MAbs also showed the presence of these proteins in all Brucella species and biovars, including the vaccine strains B. melitensis Rev. 1 and B. abortus B19. The use of these MAbs should help further study of antibody responses in sheep and other hosts and may be of considerable value for developing new diagnostic tests for ovine brucellosis.
- Published
- 1996
- Full Text
- View/download PDF
24. Enzyme-linked immunosorbent assay with partially purified cytosoluble 28-kilodalton protein for serological differentiation between Brucella melitensis-infected and B. melitensis Rev.1-vaccinated sheep.
- Author
-
Salih-Alj Debbarh H, Cloeckaert A, Bézard G, Dubray G, and Zygmunt MS
- Subjects
- Animals, Enzyme-Linked Immunosorbent Assay, Female, Sheep, Vaccination, Brucella Vaccine immunology, Brucella melitensis, Brucellosis blood
- Abstract
The problem of differentiating sheep infected with Brucella melitensis from those vaccinated or exposed to cross-reaching organisms has not been resolved by conventional serological tests or through the use of the smooth lipopolysaccharide in primary binding assays. We therefore analyzed sera from ewes experimentally infected with B. melitensis H38, from ewes naturally infected with B. melitensis, and from B. melitensis Rev.1-vaccinated ewes by enzyme-linked immunosorbent assay with three antigenic fractions: O polysaccharide, a cytosoluble protein extract (CPE) from the rough strain B. melitensis B115, and a partially purified cytosoluble protein of 28 kDa (CP28) from the CPE. Immunoglobulin G anti-O polysaccharide and anti-CPE responses were detected in all groups of animals tested (Rev.1 vaccinated and B. melitensis infected). However, false-positive reactions with CPE occurred with sera from Brucella-free ewes. The use of partially purified CP28 abolished these false-positive reactions. Furthermore, no immunoglobulin G antibodies against CP28 were detected in sera from vaccinated ewes, whereas 80% (8 of 10) of ewes experimentally infected with B. melitensis H38 and 89% (25 of 28) of naturally infected ewes showed various degrees of anti-CP28 reactivity (absorbance values of between 0.5 and 2.5). The results obtained with CP28 showed the potential usefulness of this antigen to permit the detection of B. melitensis-infected ewes and their differentiation from B. melitensis Rev.1-vaccinated ones.
- Published
- 1996
- Full Text
- View/download PDF
25. Outer-membrane protein- and rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis.
- Author
-
Bowden RA, Cloeckaert A, Zygmunt MS, and Dubray G
- Subjects
- Animals, Brucellosis prevention & control, Enzyme-Linked Immunosorbent Assay veterinary, Epididymitis prevention & control, Epididymitis veterinary, Epitopes immunology, Female, Male, Mice, Mice, Inbred BALB C, Sheep, Sheep Diseases prevention & control, Antibodies, Monoclonal immunology, Bacterial Outer Membrane Proteins immunology, Brucella immunology, Brucellosis veterinary, Immunization, Passive veterinary, Lipopolysaccharides immunology
- Abstract
Brucella ovis, a naturally virulent rough Brucella species, is the aetiological agent of ram epididymitis. The identification of protective antigens is necessary to obtain a safe, specific subcellular vaccine. Monoclonal antibodies (MAbs) directed at both brucella outer-membrane proteins (OMPs) and rough lipopolysaccharide (R-LPS) in a mouse protection test were used to identify potential targets for humoral immunity. Mixtures of MAbs directed at the 16.5-, 25-27-, 31-34- and 36-38-kDa OMPs conferred significant protection 7 days after challenge with reference strain B. ovis 63/290 compared with controls receiving either saline or an anti-brucella O-polysaccharide MAb. Furthermore, an anti-R-LPS MAb tested alone conferred protection at a level comparable with that obtained with the mixture of anti-OMP MAbs. The combination of protective OMP MAbs with the anti-R-LPS MAb was also strongly protective. One combination of OMP MAbs, which bound intensely to B. ovis in vitro, was ineffective. These results indicate that B. ovis OMPs and R-LPS are targets for protective antibodies and that they can be regarded as candidates for ram epididymitis subcellular vaccines.
- Published
- 1995
- Full Text
- View/download PDF
26. Identification of sero-reactive Brucella melitensis cytosoluble proteins which discriminate between antibodies elicited by infection and Rev.1 vaccination in sheep.
- Author
-
Debbarh HS, Cloeckaert A, Zygmunt MS, and Dubray G
- Subjects
- Animals, Antibody Formation, Antigens, Bacterial immunology, Antigens, Bacterial isolation & purification, Bacterial Proteins immunology, Bacterial Proteins isolation & purification, Brucellosis immunology, Electrophoresis, Polyacrylamide Gel, Immunoblotting, Immunoglobulin G, Sheep, Antibodies, Bacterial blood, Brucella Vaccine, Brucella abortus immunology, Brucellosis veterinary, Sheep Diseases
- Abstract
Distinction between Brucella melitensis infected and vaccinated sheep is needed to fully achieve ovine brucellosis eradication in several countries. For this purpose, we probed immunoblots of cytosoluble protein extract (CPE) of the rough (R) B. melitensis strain B115 with sera of Brucella-free, naturally infected, B. melitensis H38 experimentally infected and B. melitensis Rev.1 vaccinated sheep to identify immunogenic Brucella cytosoluble proteins which may lead to the development of more useful diagnostic tests and which may eventually differentiate vaccinated sheep from infected sheep. Brucella-free sheep sera showed IgM antibody reactivity to protein bands between 19 and 92 kDa. The use of conjugate specific for sheep IgG avoided non specific reactivity to all these bands except to the 39 and 50 kDa bands which were still detected in some Brucella-free sheep sera. In sera of B. melitensis H38 experimentally infected sheep, a specific IgG antibody response was observed against proteins of molecular masses of 19, 24, 28, 32, 39, 50 and 54 kDa. These proteins were also variably detected by IgG of sera from naturally infected sheep. Other proteins of 10, 12, 23, 36, 38, 42, 46, 68, 80 and 92 kDa were also detected by the latter sera. In sera from B. melitensis Rev.1 vaccinated sheep, an IgG antibody response was only observed against proteins with molecular masses of 39 and 50 kDa. These results suggest that the 19, 24, 28, 32 and 54 kDa proteins (the first recognized after experimental infection and that provoked a consistent humoral response during natural infection) could be interesting to develop serological tests for differentiating B. melitensis infection from B. melitensis Rev.1 vaccination.
- Published
- 1995
- Full Text
- View/download PDF
27. Brucella melitensis cell envelope protein and lipopolysaccharide epitopes involved in humoral immune responses of naturally and experimentally infected sheep.
- Author
-
Zygmunt MS, Cloeckaert A, and Dubray G
- Subjects
- Animals, Antibodies, Monoclonal immunology, Brucellosis veterinary, Enzyme-Linked Immunosorbent Assay, Immunoblotting, Sheep, Sheep Diseases immunology, Antibodies, Bacterial immunology, Bacterial Outer Membrane Proteins immunology, Brucella melitensis immunology, Brucellosis immunology, Epitopes, Lipopolysaccharides immunology
- Abstract
Cell envelope fraction (CEF) of Brucella melitensis B115 was used to investigate antibody responses of B. melitensis naturally and strain H38 experimentally infected sheep by immunoblotting, indirect enzyme-linked immunosorbent assay (ELISA) (I-ELISA), and competitive ELISA (C-ELISA) with monoclonal antibodies (MAbs). MAbs used were directed to outer membrane proteins with molecular masses of 10, 16.5, 19, 25 to 27, 31 to 34, 36 to 38, and 89 kDa; to the heat shock protein DnaK, to O-polysaccharide (O-PS) common (C) and M epitopes; and to rough lipopolysaccharide (R-LPS) epitopes. In immunoblotting, all infected sheep sera tested recognized a large number of protein bands, including the above-cited proteins and other proteins for which MAbs have not been defined. The antibody response pattern was different from one animal to another, even within the experimentally infected sheep which were infected under the same experimental conditions. A number of protein bands were recognized by the sheep sera prior to experimental infection and by other uninfected sheep sera. The antibody reactivity to these antigens and others might explain the nonspecific antibody reactivity of sera in I-ELISA with CEF. C-ELISA confirmed also the individual variability of the antibody responses of infected sheep to protein antigens. Antibody responses to O-PS C and M epitopes were detected in all experimentally infected sheep and in half of the naturally infected sheep, but these responses were also heterogeneous in relation to their intensities. Antibody responses to R-LPS epitopes detected by use of C-ELISA with the anti-R-LPS MAbs were low or negative in most of the infected animals. Despite antibody response heterogeneity for CEF antigens, immunoblot and C-ELISA results indicated that, among the CEF antigens, the O-PS epitopes (C and M epitopes) and epitopes of the major 25- to 27- and 31- to 34-kDa outer membrane proteins seem to be the most promising for detecting B. melitensis infection in sheep.
- Published
- 1994
- Full Text
- View/download PDF
28. Antibody response to Brucella melitensis outer membrane antigens in naturally infected and Rev1 vaccinated sheep.
- Author
-
Zygmunt MS, Debbarh HS, Cloeckaert A, and Dubray G
- Subjects
- Animals, Antigens, Bacterial immunology, Antigens, Surface immunology, Blotting, Western, Brucellosis immunology, Brucellosis prevention & control, Electrophoresis, Polyacrylamide Gel, Enzyme-Linked Immunosorbent Assay, Gene Products, rev immunology, Sheep, Sheep Diseases prevention & control, Vaccination veterinary, Antibodies, Bacterial biosynthesis, Brucella Vaccine immunology, Brucella melitensis immunology, Brucellosis veterinary, Sheep Diseases immunology
- Abstract
Sera from Brucella infected and B. melitensis Rev1 vaccinated sheep were analysed by immunoblotting using the cell envelope fraction (CEF) of B. melitensis B115. The CEF of B. melitensis B115 was analysed using a bank of monoclonal antibodies. The fraction consisted mainly of S-LPS like molecules, R-LPS and outer membrane proteins (OMPs) of molecular masses of 10, 16.5, 19, 25-27, 31-34, 36-38, 73 and 89 kDa. Immunoblot analysis indicates that the antibody response in infected sheep was mainly directed against the major OMPs of 25-27, 31-34, 36-38 kDa, against 55 to 62, 70-73 and 89 to 94 kDa proteins associated with the CEF and, against S-LPS like molecules. Some infected sheep reacted with antigens of molecular mass lower than 20 kDa. Sera from vaccinated sheep reacted only with OMPs of 36-38, 60, 70-73 and 89 kDa. The major 25-27 and 31-34 kDa OMPs and proteins below 20 kDa were only detected by the sera of infected sheep. These differences may be due to the persistence of the field infection also reflected by the fact that antibody response against O-polysaccharide (O-PS), as measured by enzyme-linked immunosorbent assay (ELISA), was more intense in infected sheep than in vaccinated ones. These results also indicate that these OMPs could be useful to differentiate B. melitensis infection from B. melitensis Rev.1 vaccination in sheep.
- Published
- 1994
- Full Text
- View/download PDF
29. Characterization of O-polysaccharide specific monoclonal antibodies derived from mice infected with the rough Brucella melitensis strain B115.
- Author
-
Cloeckaert A, Zygmunt MS, Dubray G, and Limet JN
- Subjects
- Animals, Antibodies, Monoclonal immunology, Brucella abortus immunology, Cross Reactions, Enzyme-Linked Immunosorbent Assay, Epitopes immunology, Hybridomas, Mice, O Antigens, Yersinia enterocolitica immunology, Antibodies, Bacterial immunology, Brucella melitensis immunology, Brucellosis immunology, Polysaccharides, Bacterial immunology
- Abstract
Twenty-two monoclonal antibodies (mAbs) specific for smooth lipopolysaccharide (S-LPS) were generated by fusion of spleen cells from mice infected with the rough Brucella melitensis strain B115 with the NSO myeloma. According to reactivity in enzyme-linked immunosorbent assay (ELISA) with O-polysaccharide (O-PS) and absence of reactivity with rough lipopolysaccharide (R-LPS), it was postulated that these mAbs recognized epitopes present on the O-PS. Most of the mAbs reacted equally well in ELISA and immunoblotting with S-LPS types of Brucella A and M dominant strains and were designated as specific for common (C) epitopes. Three mAbs were highly specific for M dominant S-LPS. All these mAbs, in contrast to a mAb specific for the A epitope, showed little or no cross-reactivity with Yersinia enterocolitica O:9 S-LPS. S-LPS of B. melitensis B115 was extracted and analysed by immunoblotting and ELISA with mAbs specific for A, M and C epitopes. Reactivity of the mAbs with this S-LPS was compared to reactivity with S-LPS of A and M dominant smooth Brucella strains. The results suggest that S-LPS of B. melitensis B115 bears mainly C epitopes and a few M epitopes. The very weak reactivity of this S-LPS with the mAb specific for the A epitope and the fact that the mAbs specific for C and M epitopes showed little or no cross-reactivity with Y. enterocolitica O:9 S-LPS suggest that O-PS from this rough strain could be used to distinguish Y. enterocolitica O:9 infection from Brucella infection.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1993
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.